FDA Approves Donanemab for Early Alzheimer’s
The US Food and Drug Administration (FDA) has approved Eli Lilly's anti-amyloid donanemab (Kisunla) 350 mg/20 mL once-monthly injection for ...
Read moreDetails
Tag: Donanemab
Donanemab for Alzheimer’s Gets Thumbs Up From FDA Panel
An 11-member advisory panel to the US Food and Drug Administration (FDA) has unanimously concluded that the investigational anti-amyloid donanemab ...
Read moreDetails
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
The Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration (FDA) will meet on ...
Read moreDetails
The Earth News is an independent English-language daily published Website from all around the World News
